James E Dunford

10PUBLICATIONS
64CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer cell biologyNatural products and bioactive compoundsCheminformatics and quantitative structure-activity relationshipsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 12, 2026
Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn's disease.

|Apr 27, 2024
The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms.

Chao-Hui Chang, Feng Liu, Stefania Militi

|May 03, 2023
HSD3B1 is an oxysterol 3β-hydroxysteroid dehydrogenase in human placenta.

Alison Dickson, Eylan Yutuc, Catherine A Thornton

|Apr 20, 2023
Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2.

Zachary W Davis-Gilbert, Andreas Krämer, James E Dunford

|Jan 11, 2023
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.

Keiji Kurata, Anna James-Bott, Mark A Tye

|Mar 31, 2021
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas.

James Heward, Lola Konali, Annalisa D'Avola

Pageof 2

Frequent Collaborators

3 joint publications

Udo Oppermann

2 joint publications

Kenneth C Anderson

2 joint publications

Yu-Tzu Tai

2 joint publications

Mehmet K Samur